Cardiology as a field of study has been gaining great significance with the increasing financial burden to the nations of the globe. Cardio vascular diseases are the number one reason for deaths globally.
Interventional cardiology is a scholarly open access journal that offers an Open Access platform to the scholars, amateurs, clinical practitioners and students that are keen in contributing their findings in this field.
Since cardiovascular diseases can be prevented by addressing behavioural risk factors Interventional cardiology journal includes wide areas of studies in this field by including apical hypertrophic cardiomyopathy, coronary artery ectasia, fetal heart calcification, chronic arterial insufficiency, cardiovascular disease and its association with cancer, peri-arrest period, complications after heart surgery, early repolarization symptoms, coronary arteritis, inflammatory vascular disease, inflammatory cardiomyopathy, systolic pressure variation, left atrium enlargement, and ventricular septal defect (VSD).
The journal offers thoroughly reviewed original research as research articles, review articles, case studies, commentaries, Short Communication, and Letters to the Editors in the areas not limited to association of abiotrophia species with heart problem, heart and blood vessel disorders, myocardial infarction (heart attack), issues of cardiac arrest, stroke, techniques and procedure used in stent implantation, anticoagulant drugs (blood thinners), basic research in heart structure and functions and other medical conditions and associated treatments etc.
The journal also focuses on the latest therapeutic efforts such as application of cardiac progenitor cells, angioplasty, percutaneous coronary intervention (PCI) such as percutaneous transluminal coronary angioplasty (PTCA), and other stent implantation, anticoagulant drugs (blood thinners), therapy after open heart surgery, use of ventricular assist device.
Interventional Cardiology is indexed in the quality indexing sites such as Scopus, EMBASE/Excerpta Medica to increase visibility and discoverability.
Review Article p. 131-137
Author(s): Carlos Alberto Paterno Marchioli
It is known that atherosclerosis is a slow, progressive disease that starts in childhood and usually manifests itself clinically much later, as it has been demonstrated by several authors [1..
Case Report p. 139-141
Author(s): John Papanikolaou, Nikolaos Platogiannis, Dionysios Gkekas, Nikolaos Barmpatzas, Konstantinos Spathoulas and Dimitrios Platogiannis
Stent thrombosis remains one of the most feared complications in patients with multiple stents implanted. In this clinical setting, optimal upfront dual antiplatelet therapy (DAPT) duration ..
Research Article p. 143-152
Author(s): Kleber Bomfim A Martins, Mauricio S de Oliveira and Luiz Alberto Mattos
Background: Statins may reduce the risk of contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI). However, there is no knowledge that PCI perform..
Research Article p. 153-162
Author(s): Nicholas Chua Yul Chye, Mohd Kamal Mohd Arshad, Rizmy Najme Khir, Lim Chiao Wen, Johan Rizwal Ismail, Effarezan Abdul Rahman, Hafisyatul Aiza, Khairul Shafiq Ibrahim, Abdul Wahab Undok, Zubin Othman Ibrahim and Sazzli Kasim
Background: Bioresorbable scaffold offer the advantages of reduced long-term complications such as stent fracture, late stent thrombosis and in-stent restenosis as well as the return of norm..